Connect with us

Health

Experts Warn of Marijuana’s Long-Term Damage to Brain and Developing Fetuses Amid Push for Reclassification

Published

on

The Biden administration’s recent proposal to reclassify marijuana as a Schedule III drug, equating it with substances like anabolic steroids and Tylenol with codeine, has ignited a contentious debate. While supporters assert that this reclassification would offer tax advantages and invigorate the cannabis industry, health experts caution about the severe negative impacts of marijuana use.

Rising Marijuana Use and Legalization Trends

A 2022 survey sponsored by the National Institutes of Health revealed that 28.8% of Americans aged 19 to 30 had used marijuana in the previous month, a rate more than three times higher than cigarette use in the same age group. Among adults aged 35 to 50, 17.3% reported using marijuana, compared to 12.2% who smoked cigarettes. Although marijuana remains federally illegal, it is now authorized for recreational use in 24 states and for medical purposes in 14 additional states.

Health Risks and Addiction

Bertha Madras, a psychobiology professor at Harvard Medical School and a leading authority on marijuana, strongly opposes the reclassification. In a recent opinion piece for the Wall Street Journal, she stated, “It’s a political decision, not a scientific one. And it’s a tragic one.” Madras, who has spent 60 years studying psychoactive drugs, underscores the high addiction potential of marijuana, especially among young people. About 30% of cannabis users develop some degree of use disorder, compared to 13.5% of alcohol users. Madras emphasizes that marijuana use is primarily aimed at intoxication and notes that academic performance and college completion rates are significantly lower among marijuana users than alcohol drinkers.

Cognitive Impairment and Driving Risks

Marijuana use significantly impairs cognitive function and driving safety. Unlike alcohol, there are no established medical “cutoff points” to determine when it’s safe to drive after using marijuana. States with legal marijuana have reported increased car accidents. “Marijuana just sits there and promotes brain adaptation,” explains Madras, noting that the substance remains in the brain much longer than alcohol.

High-Potency Marijuana and Mental Health

The potency of today’s cannabis is far greater than it was 30 years ago, with significantly higher levels of THC, the main psychoactive component. This increased potency elevates the risks of marijuana use, including anxiety, depression, impaired memory, and cannabis hyperemesis syndrome—a condition characterized by severe vomiting due to prolonged use. Madras points to evidence suggesting that cannabis can induce schizophrenia. A study of 6.9 million Danes indicated that up to 30% of schizophrenia diagnoses in young men could have been prevented if they had not become dependent on marijuana. She highlights that users of other potent recreational drugs develop chronic psychosis at much lower rates compared to marijuana users.

Impact on Pregnant Women and Children

The growing use of marijuana among pregnant women is another major concern. Marijuana use during pregnancy has been linked to higher rates of preterm births, neonatal intensive care unit admissions, lower birth weights, and smaller head circumferences. THC, the active ingredient in cannabis, crosses the placenta and affects fetal brain development. Adolescents exposed to THC in utero exhibit increased aggressive behavior, cognitive dysfunction, and symptoms of ADHD and OCD.

Lack of Medicinal Benefits

Despite widespread claims about marijuana’s medicinal benefits, Madras has found strong evidence supporting its use only for neuropathic pain. For other types of pain and conditions, high-quality trials do not provide robust evidence of benefits. She compares the current promotion of marijuana to the marketing of opioids, where benefits are exaggerated and risks minimized.

The Call for Rigorous Research

Madras disputes the claim that cannabis cannot be adequately studied while classified as a Schedule I substance. She has successfully researched THC despite the additional regulatory paperwork. Madras calls on wealthy donors and advocates to fund rigorous clinical trials instead of ballot initiatives.

Conclusion

Reclassifying marijuana would not legalize its recreational use under federal law but would enable businesses to deduct expenses and culturally signal that marijuana use is normal. Madras warns that this sets a dangerous precedent and undermines efforts to prevent addiction. “This is not a war on drugs,” she asserts. “It’s a defense of the human brain at every possible age from in utero to old age.”

The debate over marijuana reclassification highlights the need to carefully weigh potential benefits against the significant health risks outlined by experts like Madras.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Governor Bryan Pushes for Urgent Legislation to Address Medicaid Fund Shortfall

Published

on

Governor Albert Bryan announced on Monday that the territory has exhausted its funds for the local Medicaid match, prompting Government House to submit draft legislation to the Senate seeking an additional $3 million for this purpose.

Despite the fiscal shortfall, Governor Bryan views the situation as a sign of increased healthcare access. “We’re having so many people access care,” he stated, highlighting that during the pandemic, nearly 40,000 individuals utilized Medicaid for services including braces, dental care, and various medical appointments. Furthermore, eased referral requirements have facilitated access to specialty care. “Before, you had to go to East End or Frederiksted Health Center for a referral; now, a regular doctor can refer you,” Bryan explained.

These expanded services and simplified processes have rapidly depleted the Medicaid matching funds. However, Governor Bryan does not foresee this as a recurring issue, predicting stabilization next year. He noted that the V.I. Department of Human Services has already reduced some services, which has led to a decrease in Medicaid enrollment.

The proposed $3 million allocation remains critical for Virgin Islanders. Governor Bryan emphasized its importance, pointing to the recent U.S. Department of Defense Innovative Readiness Training (IRT) Program health fair, where medics served over 2,500 people seeking no-cost healthcare services. Although 6,000 people applied, many were turned away due to limited resources. The governor stressed that healthcare costs for uninsured residents ultimately fall on the territory, whether through Medicaid or hospital services.

The effort to secure adequate Medicaid funding is ongoing. In 2019, Congresswoman Stacey Plaskett successfully obtained an additional $252 million for the territory in a fiscal year 2020 spending bill, raising the federal match from 55% to 83%. This increased match rate, initially set to expire in 2021, has been made permanent, ensuring the territory receives the highest possible Medicaid match in the U.S.

Continue Reading

Health

Measles Outbreaks Prompt Vaccination Drive in U.S. Virgin Islands

Published

on

As measles outbreaks rise across the United States and the Caribbean, U.S. Virgin Islands Health Commissioner Justa Encarnacion is urging parents to prioritize their children’s vaccination schedules.

Commissioner Encarnacion voiced her concerns this week about the alarmingly low vaccination rates among children in the territory, emphasizing the imminent threat of measles. “We are very concerned about the low childhood vaccine rate in the Territory, especially with measles threatening the US,” she said. Currently, only 60 percent of USVI children are vaccinated, a situation worsened by an increasing number of parents seeking vaccination exemptions.

The urgency is underscored by the latest data from the Centers for Disease Control, which reports weekly on measles outbreaks. As of June 6, 2024, there have been 151 measles cases across 22 jurisdictions, including Arizona, California, Florida, and New York, with over half resulting in hospitalizations.

The infectiousness of measles is a significant concern for the V.I. Department of Health. “While 151 may seem like a low number, it is alarming because one person can infect nine to ten others,” Encarnacion explained. She also highlighted the risk of the disease spreading to the USVI and neighboring regions, noting that the Turks and Caicos Islands reported their first measles cases since 1991 this past May.

In response, the Department of Health launched the “Be Wise, Immunize” campaign earlier this year. This initiative aims to educate parents about the vital importance of vaccinations, stressing that immunization is the best defense against diseases like measles both in childhood and later in life.

The primary defense against measles is the measles, mumps, and rubella (MMR) vaccine, which provides long-lasting protection against all strains of the virus. Measles can lead to severe health complications, particularly in children under five, including pneumonia and encephalitis.

Measles is highly contagious, spreading through the air via coughs or sneezes from infected individuals. It remains active in the air or on surfaces for up to two hours. Symptoms typically appear seven to 14 days after exposure and include high fever, cough, runny nose, red watery eyes, and a characteristic rash.

Although declared eliminated in the United States in 2000, measles continues to persist globally and is often brought into the U.S. by unvaccinated travelers.

The VI Department of Health is urging parents to ensure their children are vaccinated and provides resources for scheduling immunization appointments at www.doh.vi.gov/immunization.

Continue Reading

Health

Douglas Koch to Lead Kearney Regional Medical Center in Nebraska

Published

on

Just a day after announcing his resignation from the Juan F. Luis Hospital (JFL) on St. Croix, CEO Douglas Koch has been named the new CEO of Kearney Regional Medical Center in Nebraska. He will assume his new role on August 5, according to a report from KSNB Local 4.

In his resignation letter, Mr. Koch cited a desire to return to the Midwest to be closer to his family. His departure has been a significant loss for local health officials, with JFL Board Chair Chris Finch expressing disappointment. Mr. Finch, who also chairs the Territorial Hospital Board of Directors, highlighted Mr. Koch’s exemplary service, noting that he had recently received an excellent personnel evaluation from board members.

Koch’s new role in Nebraska is eagerly anticipated by his future colleagues. John Woodrich, Executive Vice President and Chief Operating Officer of Bryan Health, which owns Kearney Regional, praised Koch’s midwestern roots, education, and extensive operational experience as ideal for the position. “Doug’s commitment to community health and his leadership skills will be a tremendous asset to Kearney Regional Medical Center,” said Woodrich.

Before his tenure in the U.S. Virgin Islands, Koch held leadership positions in South Dakota, Wisconsin, and Illinois. At Kearney Regional, he will oversee the expansion of inpatient facilities and the construction of a cancer center, similar to his work with JFL’s transition to a temporary modular structure. Woodrich emphasized Koch’s ability to help communities thrive, stating, “He will be an outstanding leader for Kearney Regional Medical Center.”

As Mr. Koch prepares to embark on his new journey, JFL officials now face the task of finding a new CEO to lead the hospital forward.

Continue Reading

Trending